tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (DE:8E8)
FRANKFURT:8E8
Germany Market

Elicera Therapeutics AB (8E8) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
3Neutral
3Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Elicera Therapeutics AB’s (8E8) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Elicera Therapeutics AB is a Sell.
Elicera Therapeutics AB’s (8E8) 20-Day exponential moving average is 0.48, while Elicera Therapeutics AB’s (8E8) share price is €0.47, making it a Buy.
Elicera Therapeutics AB’s (8E8) 50-Day exponential moving average is 0.49, while Elicera Therapeutics AB’s (8E8) share price is €0.47, making it a Buy.

Elicera Therapeutics AB (8E8) Pivot Points

Jan 13, 2026, 04:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.45
0.45
0.45
0.45
0.45
0.45
0.45
Fibonacci
0.45
0.45
0.45
0.45
0.45
0.45
0.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Elicera Therapeutics AB (8E8) Moving Averages

Jan 13, 2026, 04:18 PM
Period
Simple
Exponential
MA5
0.46Buy
0.47Buy
MA10
0.46Buy
0.47Buy
MA20
0.48Buy
0.48Buy
MA50
0.49Buy
0.49Buy
MA100
0.52Buy
0.49Buy
MA200
0.48Buy
0.44Buy
Elicera Therapeutics AB’s (8E8) 10-Day exponential moving average is 0.47, while Elicera Therapeutics AB’s (8E8) share price is €0.47, making it a Buy.
Elicera Therapeutics AB’s (8E8) 100-Day exponential moving average is 0.49, while Elicera Therapeutics AB’s (8E8) share price is €0.47, making it a Buy.
Elicera Therapeutics AB’s (8E8) stock price is €0.47 and Elicera Therapeutics AB’s (8E8) 50-day simple moving average is 0.49, creating a Buy signal.
Elicera Therapeutics AB’s (8E8) stock price is €0.47 and Elicera Therapeutics AB’s (8E8) 100-day simple moving average is 0.52, creating a Buy signal.
Elicera Therapeutics AB’s (8E8) stock price is €0.47 and Elicera Therapeutics AB’s (8E8) 200-day simple moving average is 0.48, creating a Buy signal.

Elicera Therapeutics AB (8E8) Technical Indicators

Jan 13, 2026, 04:18 PM
Name
Value
Implied Action
RSI (14)
62.64
Neutral
STOCH (9,6)
34.13
Neutral
STOCHRSI (14)
34.13
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
18.95
Buy
Williams %R
-2.74
Sell
CCI (14)
147.31
Sell
ATR (14)
0.01
-
Ultimate Oscillator
72.53
Buy
ROC
10.64
Buy
Elicera Therapeutics AB’s (8E8) Relative Strength Index (RSI) is 62.64, creating a Neutral signal.
Elicera Therapeutics AB’s (8E8) Trend Strength Indicator (ADX) is 18.95, creating a Buy signal.
Elicera Therapeutics AB’s (8E8) Commodity Channel Index (CCI) is 147.31, creating a Sell signal.
Elicera Therapeutics AB’s (8E8) Price Rate of Change (ROC) is 10.64, creating a Buy signal.

FAQ

Is 8E8 a Buy, Hold, or Sell?
Based on 8E8’s technical indicators, 8E8 is a Strong Buy.
    What is 8E8’s RSI (14)?
    8E8’s RSI (14) is 62.64, which suggests 8E8 is a Neutral.
      What is 8E8’s MACD?
      8E8’s MACD is >-0.01, which suggests 8E8 is a Sell.
        What is 8E8’s 5-day moving average?
        8E8’s 5-day moving average is 0.46, which suggests 8E8 is a Buy.
          What is 8E8’s 20-day moving average?
          8E8 20-day moving average is 0.48, which suggests 8E8 is a Buy.
            What is 8E8’s 50-day moving average?
            8E8’s 50-day moving average is 0.49, which suggests 8E8 is a Buy.
              What is 8E8’s 200-day moving average?
              8E8’s 200-day moving average is 0.48, which suggests 8E8 is a Buy.
                What is 8E8’s Williams % R (14)?
                8E8’s Williams % R (14) is -2.74, which suggests 8E8 is a Sell.
                  What is 8E8’s CCI (14)?
                  8E8’s CCI (14) is 147.31, which suggests 8E8 is a Sell.
                    What is the share price of Elicera Therapeutics AB?